Thoroughbred Horsemen's Association chairman Alan Foreman is confident a 2015 decision not to pursue a medication overage case against trainer Todd Pletcher won't negatively impact the National Uniform Medication Program.
Racing Medication and Testing Consortium executive director Dionne Benson said as regulators look at new, enhanced recommendations on out-of-competition testing, they're going to find policies that will work for the industry.
Racing industry won't resolve medication issues without unity read blog
The first of a two-part column on regulatory medication thresholds. read blog
The board voted to revise thresholds for three medications on the list of controlled therapeutic substances, and recommended expanding an out-of-competition testing program that would include a list of prohibited substances.
The Racing Medication and Testing Consortium Feb. 19 issued an overview of its procedures in setting withdrawal times and drug-testing threshold levels after the National HBPA said it would pursue its own research.
Protocol in the testing of equine hair samples was the focus of a racing chemist's workshop organized by the Racing Medication and Testing Consortium and held at the University of California-Davis.
Racing investigators will cover a wide range of topics when they meet for four days in March at Delaware Park in Wilmington, Del.
NTRA Safety and Integrity Alliance calls on tracks to work with their state regulators to make sure testing standards are up to par.
- By Tom LaMarra
- Horse Health, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlanic Region
The RMTC, which met Oct. 13, cited progress in state-by-state adoption of components of the National Uniform Medication Program and also added four drugs to the list of controlled substances.
A day after prominent trainer Graham Motion questioned the research conducted to determine the threshold level and withdrawal time for methocarbamol (Robaxin), the RMTC defended its efforts.
The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program.
The Louisiana State Racing Commission Aug. 24 adopted the Controlled Therapeutic Medication Schedule of 26 commonly used substances.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
At its Aug. 7 meeting, the Thoroughbred Racing Associations (TRA) board of directors reiterated its firm commitment to the implementation of uniform medication policies with a sense of urgency throughout the U.S.
The Indiana Horse Racing Commission believes Truesdail Laboratories missed seven positives, including a Class I drug, in just 26 days of handling drug tests for the state.
An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium.
The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.
Racetrack veterinarians told the Ohio State Racing Commission April 28 they support uniform medication policies, but because their top priority is the welfare of the racehorse, the state's rules should remain in place.
The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses.
The executive committee of the Racing Medication and Testing Consortium (RMTC) has approved a uniform testing threshold of 110 parts per billion (ppb) in blood for the naturally occurring amino acid gamma-aminobutyric acid.
The Racing Medication and Testing Consortium hopes to have a recommended testing threshold level by late April for a naturally occurring amino acid that has a calming effect on racehorses.
The board of directors of the Racing Medication and Testing Consortium (RMTC) today announced that a uniform threshold for cobalt regulation in the U.S. was approved at its March 24 meeting at Gulfstream Park.
Setting the testing threshold for cobalt chloride has become the challenge of racing regulators. North American racing has been well behind in its application of a satisfactory testing threshold applied across all states.
The head of the Association of Racing Commissioners International has reiterated the organization's intention to push for a uniform approach for regulation of cobalt.
As the Ohio State Racing Commission begins a comprehensive review of its medication rules and examines the National Uniform Medication Program, it has a hired a longtime veterinarian to consult on policies and procedures.
The Racing Medication and Testing Consortium may be close to recommending policy on the endogenous element cobalt, which when administered in high doses is believed to enhance production of red blood cells.
In 2014, U.S. horse racing appeared on pace to register its fewest positive drug tests for anabolic steroids since the industry moved to outlaw the drugs from racing in 2008-09. But recent events in Maryland changed that.
The sale company will follow the uniform medication model rules adopted for racing by the Association of Racing Commissioners International. Medication rule changes will begin in March.
Though the Association of Racing Commissioners International remains a member of the Racing Medication and Testing Consortium, it intends to take the lead role in gathering the information needed to set medication policies.
As part of an examination of its equine medication rules, the Ohio State Racing Commission in February will begin hearing from various industry organizations involved in an effort to adopt uniform policies for all states.
The industry's Racing Medication and Testing Consortium plans to reorganize its own Scientific Advisory Committee but does not plan to merge with the Association of Racing Commissioners International.
The Association of Racing Commissioners International board has selected five initial members for its new Drug Testing Standards and Practices Committee.
The Association of Racing Commissioners International has asked that the industry's Racing Medication and Testing Consortium be merged into a new RCI scientific advisory board.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
The Breeders' Cup World Championships will be held for the first time under reforms included in the National Uniform Medication Program.
The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
- By Tom LaMarra
Research commissioned by The Jockey Club shows that, though the Thoroughbred industry has made progress in the area of uniform medication and testing standards, a state-by-state approach is at best problematic.
- By Tom LaMarra
United States Trotting Association-funded research into cobalt has resulted in a regulatory testing threshold of 70 parts per billion, the organization said Sept. 30.
The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
No getting around the need for a national medication policy. read blog
The Jockey Club Aug. 10 acknowledged progress on the effort to adopt uniform medication and drug-testing rules on a state-by-state basis, but also said it will advocate on the federal level for assistance.
Following a presentation by RMTC executive director Dionne Benson, the Thoroughbred Owners and Breeders Association has issued a statement pledging support of the uniform medication program.
Advocates for change in horse racing didn't find much reason for optimism in the National Thoroughbred Racing Association's legislative update held in Saratoga Springs Aug. 7.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Racing Medication and Testing Consortium executive director Dionne Benson discussed the implications of a British steroid ban on U.S. horses Aug. 6 during TOBA's annual members meeting.
Before making a formal recommendation of a regulatory testing limit on cobalt, North American racing regulators have decided to consider the results of two scientific research studies.
The West Virginia Racing Commission Aug. 1 hired Truesdail Laboratories in California to handle its equine drug testing and will ask the lab to test about 40 "cloudy samples" from a three-week period in July.
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
Most Popular Stories
- Derby Observations, Strategy, and Wagers
- Routine, Quiet Oaks Morning on Backside
- Nyquist Draws Post 13, is 3-1 Derby Favorite
- Field of 22 Set for 142nd Kentucky Derby
- Derby by the Speed Numbers
- NBC Offers Virtual Kentucky Derby Experience
- Unlocking Winners Kentucky Derby 142 Analysis
- Team Optimistic, Nyquist 'Full of Energy'
- Repole Returns With Outwork for Uncle Mo
- Beholder to Make 2016 Debut in Adoration